Conference abstractPublished 2 Jun 2025
Stimulant use and comorbid tic disorders in the pediatric population: Clinical considerations and treatment implications
Brigham Young University, United States.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Attention-Deficit/Hyperactivity Disorder (ADHD) is frequently treated with stimulant medications such as methylphenidate and amphetamines. However, concerns persist regarding the potential exacerbation or onset of tic disorders in children receiving stimulant therapy which often leads to hesitancy to begin or continue treatment. The U.S. Food and Drug Administration (FDA) has issued warnings about stimulant-induced tics, included in the packaging of dextroamphetamine (Adderall). There is conflicting evidence concerning the worsening of tics as a side effect to simulants, highlighting the need for careful clinical evaluation in patients with comorbid tic disorders prior to starting medication regimens. This study examines the relationship between stimulant use and tic disorders to inform clinical decision-making based on current published data.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Neurology and Neurosurgery
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Brandon Krout”
